Literature DB >> 11384531

HIV-1 group O infection in Cameroon, 1986 to 1998.

A Ayouba1, P Mauclère, P M Martin, P Cunin, J Mfoupouendoun, B Njinku, S Souquières, F Simon.   

Abstract

We report a survey of HIV-1 group O infection in Cameroon during 1986 to 1998. The prevalence of HIV-1/O decreased from 0.6% to 0.4%, while HIV-1/M increased from 19.2% to 31.5% from 1994 to 1998. We concluded that HIV-1/O infection is stable in Cameroon and may be declining slightly.

Entities:  

Mesh：

Year:  2001        PMID： 11384531      PMCID： PMC2631804          DOI： 10.3201/eid0703.010321

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  20 in total

1.  Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase.

Authors:  J Mercier; R C Levesque
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

2.  DNA polymorphisms amplified by arbitrary primers are useful as genetic markers.

Authors:  J G Williams; A R Kubelik; K J Livak; J A Rafalski; S V Tingey
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

Review 3.  Class 1 integrons, gene cassettes, mobility, and epidemiology.

Authors:  A C Fluit; F J Schmitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-11       Impact factor: 3.267

4.  The structure of beta-lactamases.

Authors:  R P Ambler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1980-05-16       Impact factor: 6.237

5.  Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Authors:  L Poirel; T Naas; D Nicolas; L Collet; S Bellais; J D Cavallo; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

6.  An analysis of hospital-acquired bacteraemia in intensive care unit patients in a university hospital in Kuwait.

Authors:  W Y Jamal; K El-Din; V O Rotimi; T D Chugh
Journal:  J Hosp Infect       Date:  1999-09       Impact factor: 3.926

7.  PCR mapping of integrons reveals several novel combinations of resistance genes.

Authors:  C Lévesque; L Piché; C Larose; P H Roy
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

8.  Integrons found in different locations have identical 5' ends but variable 3' ends.

Authors:  R M Hall; H J Brown; D E Brookes; H W Stokes
Journal:  J Bacteriol       Date:  1994-10       Impact factor: 3.490

9.  Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases.

Authors:  P Nordmann; T Naas
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

10.  Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993.

Authors:  H Y Chen; M Yuan; D M Livermore
Journal:  J Med Microbiol       Date:  1995-10       Impact factor: 2.472
View more
  32 in total

1.  The molecular population genetics of HIV-1 group O.

Authors:  Philippe Lemey; Oliver G Pybus; Andrew Rambaut; Alexei J Drummond; David L Robertson; Pierre Roques; Michael Worobey; Anne-Mieke Vandamme
Journal:  Genetics       Date:  2004-07       Impact factor: 4.562

2.  Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtide.

Authors:  Agnès Depatureaux; Charlotte Charpentier; Gilles Collin; Marie Leoz; Diane Descamps; Aurélia Vessière; Florence Damond; Dominique Rousset; Françoise Brun-Vézinet; Jean-Christophe Plantier
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

3.  HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs.

Authors:  Denis M Tebit; Hamish Patel; Annette Ratcliff; Elodie Alessandri; Joseph Liu; Crystal Carpenter; Jean-Christophe Plantier; Eric J Arts
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-16       Impact factor: 2.205

4.  The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates.

Authors:  Kevin K Ariën; Awet Abraha; Miguel E Quiñones-Mateu; Luc Kestens; Guido Vanham; Eric J Arts
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 5.  Origin and diversity of human retroviruses.

Authors:  Martine Peeters; Mirela D'Arc; Eric Delaporte
Journal:  AIDS Rev       Date:  2014 Jan-Mar       Impact factor: 2.500

6.  Origin and biology of simian immunodeficiency virus in wild-living western gorillas.

Authors:  Jun Takehisa; Matthias H Kraus; Ahidjo Ayouba; Elizabeth Bailes; Fran Van Heuverswyn; Julie M Decker; Yingying Li; Rebecca S Rudicell; Gerald H Learn; Cecile Neel; Eitel Mpoudi Ngole; George M Shaw; Martine Peeters; Paul M Sharp; Beatrice H Hahn
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

7.  High GUD incidence in the early 20 century created a particularly permissive time window for the origin and initial spread of epidemic HIV strains.

Authors:  João Dinis de Sousa; Viktor Müller; Philippe Lemey; Anne-Mieke Vandamme
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

8.  Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections.

Authors:  J-C Plantier; M Djemai; V Lemée; A Reggiani; M Leoz; L Burc; A Vessière; D Rousset; J-D Poveda; C Henquell; A Gautheret-Dejean; F Barin
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

9.  Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees.

Authors:  Jun Takehisa; Matthias H Kraus; Julie M Decker; Yingying Li; Brandon F Keele; Fréderic Bibollet-Ruche; Kenneth P Zammit; Zhiping Weng; Mario L Santiago; Shadrack Kamenya; Michael L Wilson; Anne E Pusey; Elizabeth Bailes; Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

10.  Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon.

Authors:  Avelin F Aghokeng; Eitel Mpoudi-Ngole; Henriette Dimodi; Arrah Atem-Tambe; Marcel Tongo; Christelle Butel; Eric Delaporte; Martine Peeters
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.